2021
DOI: 10.1107/s0108767321088188
|View full text |Cite
|
Sign up to set email alerts
|

Crystal growth and optical study of thalidomide

Abstract: Thalidomide (TD) was first developed as a safe sedative hypnotic in 1958 and was prescribed for pregnant women to prevent morning sickness. However, TD was reported to cause the tragic side effect in 1960s: Babies born to mothers who took TD had small limb or malfunctioning organs. Nevertheless, TD has attracted much attention as an indispensable pharmaceutical compound because of its effectiveness in treating intractable diseases. Meanwhile, Blaschke et al. reported that only (S)-isomer of TD caused its terat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 7 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?